AN2 Therapeutics Statistics
Total Valuation
ANTX has a market cap or net worth of $83.22 million. The enterprise value is -$30.99 million.
| Market Cap | 83.22M |
| Enterprise Value | -30.99M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ANTX has 29.83 million shares outstanding. The number of shares has increased by 53.53% in one year.
| Shares Outstanding | 29.83M |
| Shares Change (YoY) | +53.53% |
| Shares Change (QoQ) | +26.12% |
| Owned by Insiders (%) | 25.37% |
| Owned by Institutions (%) | 70.52% |
| Float | 11.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.75 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.91, with zero debt.
| Current Ratio | 10.91 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -57.20% and return on invested capital (ROIC) is -65.00%.
| Return on Equity (ROE) | -57.20% |
| Return on Assets (ROA) | -51.50% |
| Return on Capital (ROIC) | -65.00% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.61M |
| Employee Count | 41 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.77% in the last 52 weeks. The beta is -0.12, so ANTX's price volatility has been lower than the market average.
| Beta (5Y) | -0.12 |
| 52-Week Price Change | -64.77% |
| 50-Day Moving Average | 2.26 |
| 200-Day Moving Average | 9.44 |
| Relative Strength Index (RSI) | 62.86 |
| Average Volume (20 Days) | 161,573 |
Short Selling Information
The latest short interest is 676,962, so 2.27% of the outstanding shares have been sold short.
| Short Interest | 676,962 |
| Short Previous Month | 707,266 |
| Short % of Shares Out | 2.27% |
| Short % of Float | 5.84% |
| Short Ratio (days to cover) | 4.52 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -71.89M |
| Pretax Income | -66.03M |
| Net Income | -66.03M |
| EBITDA | -65.99M |
| EBIT | -66.03M |
| Earnings Per Share (EPS) | -$2.54 |
Balance Sheet
The company has $114.21 million in cash and no debt, giving a net cash position of $114.21 million or $3.83 per share.
| Cash & Cash Equivalents | 114.21M |
| Total Debt | n/a |
| Net Cash | 114.21M |
| Net Cash Per Share | $3.83 |
| Equity (Book Value) | 110.60M |
| Book Value Per Share | 3.71 |
| Working Capital | 105.65M |
Cash Flow
| Operating Cash Flow | -59.29M |
| Capital Expenditures | n/a |
| Free Cash Flow | -59.29M |
| FCF Per Share | -$1.99 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ANTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -53.53% |
| Shareholder Yield | -53.53% |
| Earnings Yield | -79.34% |
| FCF Yield | -71.24% |
Analyst Forecast
The average price target for ANTX is $4.00, which is 43.37% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.00 |
| Price Target Difference | 43.37% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |